Background: The benefits of sentinel lymph node biopsy (SLNB) for breast cancer patients with histologically negative axillary nodes, in whom axillary lymph node dissection (ALND) is thereby avoided, ...
SLN is trading in the middle of its 52-week range and above its 200-day simple moving average. Price change The price of SLN shares has decreased $0.08 since the market last closed. This is a 1.09% ...
Silence Therapeutics plc (NASDAQ:SLN) missed earnings with its latest quarterly results, disappointing overly-optimistic forecasters. Statutory earnings fell substantially short of expectations, with ...
The study was approved by the Ethics Committee of the Ministry of Health of Jamaica. Informed consent was received from all participating patients. All patients of either gender presenting to the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback